Thu, May 23, 2013, 1:37 PM EDT - U.S. Markets close in 2 hrs 23 mins
Good earning, good outlook. This stock will go back to above $20.
Don't be tricked by the short sellers.
"Abiomed Announces Revenue of $37.4 Million, Up 27% and Worldwide Impella(R) Revenue Growth of 32%"
Sentiment: Strong Buy
Insurers may balk and subpoena- utilization will likely suffer. BUY CALLS LEAPS
Why the drop ???? I just don't get it